Skip to main content
Clinical Trials/JPRN-UMIN000009432
JPRN-UMIN000009432
Recruiting
Phase 2

A pilot study of the preoperative chemoradiotherapy for T3-4, N0-N2 rectal cancer aiming at sphincter preservation. - The preoperative chemoradiotherapy for T3-4, N0-N2 rectal cancer

Saitama Medical Center, Saitama Medical University0 sites28 target enrollmentNovember 29, 2012
ConditionsRectal cancer

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Rectal cancer
Sponsor
Saitama Medical Center, Saitama Medical University
Enrollment
28
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 29, 2012
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Saitama Medical Center, Saitama Medical University

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\. Patients with severe organ disfunction 2\. Patients with uncontrollable ascites and pleural effusion 3\. Patients with gastrointestinal bleeding 4\. Patients with severe infection 5\. Patients with severe complications 6\. Synchronous or metachronous malignancy 7\. Patients who have undergone abdominal radiotherapy 8\. Patients with severe mental disorders 9\. Women who are unwilling to avoid pregnancy. Women who are pregnant or breastfeeding. 10\. Any other cases who are regarded as inadequate for study enrollmet by investigators

Outcomes

Primary Outcomes

Not specified

Similar Trials